Jersey City
-
GSK Strikes Another Antimicrobial Deal, Paying $90M for Scynexis’s Brexafemme
GSK acquired global rights to Brexafemme, a novel antifungal from Scynexis that is approved for treating vaginal yeast infections. The deal also gives GSK the chance to commercialize the drug in other indications.
-
Organon makes another women’s health move with deal for endometriosis-focused Forendo
Organon’s proposed acquisition of Forendo Pharma is the company’s third since spinning out of Merck in the summer. Clinical-stage Forendo is developing a new, potentially more targeted approach to treating endometriosis.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Scynexis antifungal drug secures FDA nod; first approval in new class in 20 years
The FDA has approved Brexafemme, a Scynexis antifungal drug, for treating vaginal yeast infections. The drug is the biotech’s first FDA-approved product and it also represents the first new antifungal drug class in 20 years.
-
Apprentice secures $2.5M for augmented reality tool geared toward biopharma manufacturing
Apprentice, a Jersey City, New Jersey-based startup, has raised $2.5 million from Silverton Partners and Hemi Ventures to improve its augmented reality solution.
-
Here’s a not-so-sexy cloud startup that just raised $10M from GE, NEA
GE leads a $10 million round in a company that intends to make the management of hospital clinical and non-clinical capital equipment headache free and mobile enabled.
-
ALS disrupted: FDA approves Japanese drug that slows decline by 33%
Late Friday, MT Pharma America broke the news that the FDA had approved its experimental amyotrophic lateral sclerosis (ALS) drug Radicava, the second-ever drug approved for ALS and the first in over 20 years.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
